<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int. J. Oncol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1019-6439</issn>
      <issn pub-type="epub">1791-2423</issn>
      <publisher>
        <publisher-name>D.A. Spandidos</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26708416</article-id>
      <article-id pub-id-type="pmc">4750536</article-id>
      <article-id pub-id-type="doi">10.3892/ijo.2015.3310</article-id>
      <article-id pub-id-type="publisher-id">ijo-48-03-1242</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fusion of the <italic>TBL1XR1</italic> and <italic>HMGA1</italic> genes in splenic hemangioma with t(3;6)(q26;p21)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>PANAGOPOULOS</surname>
            <given-names>IOANNIS</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijo-48-03-1242">1</xref>
          <xref ref-type="aff" rid="af2-ijo-48-03-1242">2</xref>
          <xref ref-type="corresp" rid="c1-ijo-48-03-1242"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GORUNOVA</surname>
            <given-names>LUDMILA</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijo-48-03-1242">1</xref>
          <xref ref-type="aff" rid="af2-ijo-48-03-1242">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BJERKEHAGEN</surname>
            <given-names>BODIL</given-names>
          </name>
          <xref ref-type="aff" rid="af3-ijo-48-03-1242">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LOBMAIER</surname>
            <given-names>INGVILD</given-names>
          </name>
          <xref ref-type="aff" rid="af3-ijo-48-03-1242">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HEIM</surname>
            <given-names>SVERRE</given-names>
          </name>
          <xref ref-type="aff" rid="af1-ijo-48-03-1242">1</xref>
          <xref ref-type="aff" rid="af2-ijo-48-03-1242">2</xref>
          <xref ref-type="aff" rid="af4-ijo-48-03-1242">4</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-ijo-48-03-1242"><label>1</label>Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway</aff>
      <aff id="af2-ijo-48-03-1242"><label>2</label>Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway</aff>
      <aff id="af3-ijo-48-03-1242"><label>3</label>Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway</aff>
      <aff id="af4-ijo-48-03-1242"><label>4</label>Faculty of Medicine, University of Oslo, Oslo, Norway</aff>
      <author-notes>
        <corresp id="c1-ijo-48-03-1242">Correspondence to: Dr Ioannis Panagopoulos, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, P.O. Box 4953 Nydalen, NO-0424 Oslo, Norway, E-mail: <email>ioannis.panagopoulos@rr-research.no</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>48</volume>
      <issue>3</issue>
      <fpage>1242</fpage>
      <lpage>1250</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Panagopoulos et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>RNA-sequencing of a splenic hemangioma with the karyotype 45~47,XX,t(3;6)(q26;p21) showed that this translocation generated a chimeric <italic>TBL1XR1-HMGA1</italic> gene. This is the first time that this tumor has been subjected to genetic analysis, but the finding of an acquired clonal chromosome abnormality in cells cultured from the lesion and the presence of the <italic>TBL1XR1-HMGA1</italic> fusion in them strongly favor the conclusion that splenic hemangiomas are of a neoplastic nature. Genomic PCR confirmed the presence of the <italic>TBL1XR1-HMGA1</italic> fusion gene, and RT-PCR together with Sanger sequencing verified the presence of the fusion transcripts. The molecular consequences of the t(3;6) would be substantial. The cells carrying the translocation would retain only one functional copy of the wild-type <italic>TBL1XR1</italic> gene while the other, rearranged allele could produce a putative truncated form of TBL1XR1 protein containing the LiSH and F-box-like domains. In the <italic>TBL1XR1-HMGA1</italic> fusion transcript, furthermore, untranslated exons of <italic>HMGA1</italic> are replaced by the first 5 exons of the <italic>TBL1XR1</italic> gene. The result is that the entire coding region of <italic>HMGA1</italic> comes under the control of the <italic>TBL1XR1</italic> promoter, bringing about dysregulation of <italic>HMGA1</italic>. This is reminiscent of similar pathogenetic mechanisms involving high mobility genes in benign connective tissue tumors such as lipomas and leiomyomas.</p>
      </abstract>
      <kwd-group>
        <kwd>splenic hemangioma</kwd>
        <kwd>chromosomal translocation</kwd>
        <kwd>fusion gene</kwd>
        <kwd>RNA sequencing</kwd>
        <kwd>chimeric TBL1XR1-HMGA1 gene</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Splenic hemangiomas, although infrequent, represent the most common benign neoplasms of the spleen with an incidence of 0.03&#x2013;14% found in large autopsy series (<xref rid="b1-ijo-48-03-1242" ref-type="bibr">1</xref>,<xref rid="b2-ijo-48-03-1242" ref-type="bibr">2</xref>). In the vast majority of cases, splenic hemangiomas are incidental surgical, radiologic, or autopsy findings, made during evaluation for other disorders (<xref rid="b1-ijo-48-03-1242" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-ijo-48-03-1242" ref-type="bibr">3</xref>). Arber <italic>et al</italic> (<xref rid="b3-ijo-48-03-1242" ref-type="bibr">3</xref>) reported 7 localized splenic hemangiomas all of which were discovered incidentally in surgical patients. In a large series of 32 patients with splenic hemangioma, only 6 presented with abdominal symptoms and only 4 had a palpable spleen (<xref rid="b1-ijo-48-03-1242" ref-type="bibr">1</xref>).</p>
      <p>Because of the general absence of presenting symptoms and the typically incidental nature of splenic hemangiomas, the age at presentation varies considerably. Several non-autopsy, surgical series revealed an average age at detection/presentation of between 51 and 63 years (<xref rid="b1-ijo-48-03-1242" ref-type="bibr">1</xref>,<xref rid="b3-ijo-48-03-1242" ref-type="bibr">3</xref>). However, examination of autopsy data reveals a much younger average patient age (<xref rid="b4-ijo-48-03-1242" ref-type="bibr">4</xref>) indicating that these benign lesions are likely to be present but remain undetected for long periods of time. No gender or race predilection has been reported (<xref rid="b1-ijo-48-03-1242" ref-type="bibr">1</xref>).</p>
      <p>Splenic hemangiomas are thought to be congenital in origin, arising from sinusoidal epithelium (<xref rid="b5-ijo-48-03-1242" ref-type="bibr">5</xref>). Whether they are neoplastic or represent some other type of misgrowth, remains uncertain. They typically appear as circumscribed, non-encapsulated, honeycomb-like, red-purple masses that frequently blend imperceptibly into the surrounding splenic parenchyma (<xref rid="b4-ijo-48-03-1242" ref-type="bibr">4</xref>). The spaces are composed of sponge-like tissue filled with blood and separated by fibrous septa. Occasional calcification may be seen, often in association with an organized infarct (<xref rid="b6-ijo-48-03-1242" ref-type="bibr">6</xref>). Microscopically, the majority of hemangiomas are cavernous in nature, consisting of large interconnected, dilated, blood-filled spaces lined by a monolayer of cytologically bland endothelial cells separated by thin fibrous septa or splenic pulp tissue. Pure capillary architecture is less common. Instead, many lesions contain varying proportions of both cavernous and capillary components (<xref rid="b4-ijo-48-03-1242" ref-type="bibr">4</xref>). Immunophenotypically, splenic hemangiomas show reactivity of endothelial lining cells for CD31, von Willebrand factor, Ulex europeaus, lectin I, and CD34. This pattern raises the possibility that splenic hemangioma may derive from a combination of splenic venous structures as well as from splenic sinusoidal cells (<xref rid="b4-ijo-48-03-1242" ref-type="bibr">4</xref>).</p>
      <p>Most splenic hemangiomas tend to be small in size (&lt;4 cm) although lesions &#x2264;36 cm have been reported (<xref rid="b4-ijo-48-03-1242" ref-type="bibr">4</xref>). They need not be entirely without complications as larger lesions may rupture with resulting intra-abdominal hemorrhage (<xref rid="b7-ijo-48-03-1242" ref-type="bibr">7</xref>&#x2013;<xref rid="b11-ijo-48-03-1242" ref-type="bibr">11</xref>). In some patients, they cause the Kasabach-Meritt syndrome (<xref rid="b12-ijo-48-03-1242" ref-type="bibr">12</xref>).</p>
      <p>The etiology and pathogenesis of splenic hemangiomas are unclear and no cytogenetic or molecular genetic information about the disease has been published. We here describe the cytogenetic analysis of a splenic hemangioma and the fusion gene corresponding to the chromosomal translocation thus found.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>Ethical approval</title>
        <p>The study was approved by the Regional Committee for Medical and Health Research Ethics, SouthEast Norway (REK S&#xF8;r) <ext-link ext-link-type="uri" xlink:href="http://helseforskning.etikkom.no">http://helseforskning.etikkom.no</ext-link>). Written informed consent was obtained from the patient. The consent included acceptance that the clinical details be published. The ethics committee's approval included a review of the consent procedure. All patient information has been anonymized and de-identified.</p>
      </sec>
      <sec>
        <title>Patient</title>
        <p>A twenty-nine-year-old woman was incidentally diagnosed with a splenic hemangioma during an ultrasound examination for cholecystitits. She had been without symptoms attributable to the splenic lesion, possibly except some pressure in the upper left abdomen. Because of continuous growth of the hemangioma, it was decided to do a splenectomy. Histological examination (<xref rid="f1-ijo-48-03-1242" ref-type="fig">Fig. 1</xref>) showed that the lesion was composed of large, blood-filled vessels lined by flat endothelium and separated by thin fibrous septa or splenic pulpa. Immunohistochemical analysis showed positivity for CD31 and ERG.</p>
      </sec>
      <sec>
        <title>Control sample</title>
        <p>The control sample was FirstChoice human spleen total RNA (Life Tehnologies, Carlsbad, CA, USA).</p>
      </sec>
      <sec>
        <title>G-banding and karyotyping</title>
        <p>Fresh tissue from a representative area of the tumor was received and analyzed cytogenetically as part of our diagnostic routine. The sample was disaggregated mechanically and enzymatically with collagenase II (Worthington, Freehold, NJ, USA). The resulting cells were cultured and harvested using standard techniques. Chromosome preparations were G-banded with Wright stain and examined. Peripheral blood lymphocytes stimulated with phytohemagglutinin (PHA) for 72 h were also karyotyped. The karyotypes were written according to the International System for Human Cytogenetic Nomenclature (ISCN) 2009 guidelines (<xref rid="b13-ijo-48-03-1242" ref-type="bibr">13</xref>).</p>
      </sec>
      <sec>
        <title>RNA and DNA extraction</title>
        <p>Tumor tissue adjacent to that used for cytogenetic analysis and histologic examination had been frozen and stored at &#x2212;80&#xB0;C. Total RNA was extracted using miRNeasy Mini kit according to the manufacturer's instructions (Qiagen Nordic, Oslo, Norway). Tumor tissue was disrupted and homogenized in Qiazol Lysis Reagent (Qiagen) using a 5-mm stainless steel bead and TissueLyser II (Qiagen). Subsequently, total RNA was purified using QIAcube (Qiagen). The RNA quality was evaluated using the Experion Automated Electrophoresis system (Bio-Rad Laboratories, Oslo, Norway). The RNA quality indicator (RQI) was 9.0. Genomic DNA was extracted using the Maxwell 16 Instrument System and the Maxwell 16 Tissue DNA Purification kit (Promega, Madison, WI, USA), and the concentration and purity of DNA were measured using NanoVue Plus Spectrophotometer (GE Healthcare Life Sciences, Oslo, Norway).</p>
      </sec>
      <sec>
        <title>High-throughput paired-end RNA-sequencing</title>
        <p>Three micrograms of total RNA were sent for high-throughput paired-end RNA-sequencing at the Norwegian Sequencing Centre, Ullev&#xE5;l Hospital (<ext-link ext-link-type="uri" xlink:href="http://www.sequencing.uio.no/">http://www.sequencing.uio.no/</ext-link>). The RNA was sequenced using an Illumina HiSeq 2000 instrument and the Illumina software pipeline was used to process image data into raw sequencing data. The regular TruSeq library preparation protocol (<ext-link ext-link-type="uri" xlink:href="http://support.illumina.com/downloads/truseq_rna_sample_preparation_guide_15008136.ilmn">http://support.illumina.com/downloads/truseq_rna_sample_preparation_guide_15008136.ilmn</ext-link>) was used. The reads obtained had a length of 100 base pairs (bp). A total of 74 million reads were obtained. The quality of the raw sequence data was assessed using FastQC software (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). The software TopHat-Fusion was used for the discovery of fusion transcripts (<xref rid="b14-ijo-48-03-1242" ref-type="bibr">14</xref>,<xref rid="b15-ijo-48-03-1242" ref-type="bibr">15</xref>). To verify further the fusion gene which was found by TopHat-Fusion, the &#x2018;grep&#x2019; command (<ext-link ext-link-type="uri" xlink:href="http://en.wikipedia.org/wiki/Grep">http://en.wikipedia.org/wiki/Grep</ext-link>) was used to search the fastq files of sequence data (<ext-link ext-link-type="uri" xlink:href="http://en.wikipedia.org/wiki/FASTQ_format">http://en.wikipedia.org/wiki/FASTQ_format</ext-link>). Our &#x2018;specific expression&#x2019; was a sequence of 20 nucleotides at the fusion point, 10 bases upstream (5&#x2032;-end gene), and 10 bases downstream from the junction (3&#x2032;-end gene). The expression was &#x2018;CGACCAATAGGTCCCCAAGT&#x2019;. The sequences obtained by &#x2018;grep&#x2019; were blasted against the human genomic plus transcript database (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>) as well as the sequences with accession numbers NM_024665.4 (<italic>TBL1XR1</italic>) and NM_002131.3 (<italic>HMGA1</italic>) and DB051170.1 (TESTI2 <italic>Homo sapiens</italic> cDNA clone TESTI2040990, 5&#x2032;, mRNA sequence).</p>
      </sec>
      <sec>
        <title>RT-PCR and genomic PCR analyses</title>
        <p>The primers used for PCR amplification and Sanger sequencing are listed in <xref rid="tI-ijo-48-03-1242" ref-type="table">Table I</xref>. For RT-PCR, 1 &#x3BC;g of total RNA was reverse-transcribed in a 20-&#x3BC;l reaction volume using iScript Advanced cDNA Synthesis kit for RT-qPCR according to the manufacturer's instructions (Bio-Rad Laboratories). The 25 &#x3BC;l PCR volume contained 12.5 &#x3BC;l Premix Ex Taq&#x2122; DNA Polymerase Hot Start Version (Takara Bio Europe/SAS, Saint-Germain-en-Laye, France), 1 &#x3BC;l of cDNA, and 0.4 &#x3BC;M of each of the forward and reverse primer. The primer sets TBL1XR1-229F1/DB051170-Intr2R1 and TBL1XR1-229F1/HMGA1-324R1 were used to detect possible <italic>TBL1XR1-HMGA1</italic> fusion transcripts. The quality of the cDNA synthesis was examined by amplification of a cDNA fragment of the <italic>ABL1</italic> gene using the primers ABL1-91F1 and ABL1-404R1 (<xref rid="b16-ijo-48-03-1242" ref-type="bibr">16</xref>).</p>
        <p>For genomic PCR, the 25 &#x3BC;l PCR volume contained 12.5 &#x3BC;l Premix Ex Taq&#x2122; DNA Polymerase Hot Start Version, 100 ng DNA, and 0.4 &#x3BC;M of each of the forward and reverse primers TBL1XR1-intron4-F1 and DB051170-intr2R1.</p>
        <p>The PCR amplifications were run on a C-1000 Thermal cycler (Bio-Rad Laboratories) with an initial denaturation at 94&#xB0;C for 30 sec, followed by 35 cycles of 7 sec at 98&#xB0;C, 30 sec at 55&#xB0;C (58&#xB0;C for genomic PCR), 1 min at 72&#xB0;C, and a final extension for 5 min at 72&#xB0;C. For amplification of the ABL1 cDNA fragment, the PCR cycling was an initial denaturation at 94&#xB0;C for 30 sec followed by 35 cycles of 7 sec at 98&#xB0;C and 2 min at 68&#xB0;C, and a final extension for 5 min at 68&#xB0;C. Three microliters of the PCR products were stained with GelRed (Biotium, Hayward, CA, USA), analysed by electrophoresis through 1.0% agarose gel, and photographed. The remaining 22 &#x3BC;l PCR products were purified using the MinElute PCR purification kit (Qiagen Nordic) and sequenced at GATC Biotech (Germany, <ext-link ext-link-type="uri" xlink:href="http://www.gatc-biotech.com/en/home.html">http://www.gatc-biotech.com/en/home.html</ext-link>). The BLAST software (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>) was used for computer analysis of sequence data.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>G-banding</title>
        <p>The G-banding analysis of the splenic hemangioma yielded a karyotype with a single clonal chromosome abnormality: 45~47,XX,t(3;6)(q26;p21)[cp22] (<xref rid="f2-ijo-48-03-1242" ref-type="fig">Fig. 2</xref>). The G-banding analysis of PHA-stimulated peripheral blood cells yielded a normal 46,XX karyotype. Thus, the translocation t(3;6)(q26;p21) was found in cells of the splenic hemangioma only.</p>
      </sec>
      <sec>
        <title>High-throughput paired-end RNA-sequencing analysis</title>
        <p>Using the TopHat-Fusion on the raw sequencing data obtained by Norwegian Sequencing Centre, four fusions were found between chromosome bands 3q26 and 6p21 (<xref rid="tII-ijo-48-03-1242" ref-type="table">Table II</xref>). Among them was a fusion between <italic>TBL1XR1</italic> (from 3q26) and the sequence with accession number DB051170 which is an alternative splicing transcript of <italic>HMGA1</italic> found in testis (<xref rid="b17-ijo-48-03-1242" ref-type="bibr">17</xref>).</p>
        <p>In order to verify this fusion, we used the &#x2018;grep&#x2019; command utility to search for expressions composed of 10 nt of <italic>TBL1XR1</italic> and 10 nt of <italic>HMGA1</italic> upstream and downstream of the fusion point (<xref rid="tIII-ijo-48-03-1242" ref-type="table">Table III</xref>). Using the expression &#x2018;CGACCAATAGGTCCCCAAGT&#x2019;, which is composed of 10 nt, &#x2018;CGACCAATAG&#x2019;, from <italic>TBL1XR1</italic> and 10 nt, &#x2018;GTCCCCAAGT&#x2019;, from <italic>HMGA1</italic>, 16 sequences were retrieved. BLAT of these sequences on the human genome browser-hg19 assembly (<ext-link ext-link-type="uri" xlink:href="http://genome-euro.ucsc.edu/cgi-bin/hgGateway">http://genome-euro.ucsc.edu/cgi-bin/hgGateway</ext-link>) showed that they were chimeric cDNA fragments composed of nucleotides which mapped on 3q26 in the coding region of <italic>TBL1XR1</italic> and nucleotides mapped on chromosome band 6p21, circa 700 bp upstream of the <italic>HMGA1</italic> sequence with accession number NM_002131 and within the sequence with accession number DB051170 which is an alternative splicing transcript of <italic>HMGA1</italic> found in testis (<xref rid="b17-ijo-48-03-1242" ref-type="bibr">17</xref>). The fusion had occurred between nt 496 of <italic>TBL1XR1</italic> mRNA reference sequence NM_024665.4 and nt 215 of the sequence with accession number DB051170.1 (<xref rid="tIII-ijo-48-03-1242" ref-type="table">Table III</xref>). We therefore decided to investigate the tumor further for the presence of the <italic>TBL1XR1-HMGA1</italic> fusion transcript using molecular techniques. No other fusions were examined.</p>
      </sec>
      <sec>
        <title>Molecular genetic confirmation of the TBL1XR1-HMGA1 fusion</title>
        <p>A 338-bp <italic>ABL1</italic> cDNA fragment was amplified indicating the good quality of the synthesized cDNA (<xref rid="f3-ijo-48-03-1242" ref-type="fig">Fig. 3A</xref>).</p>
        <p>To verify the data obtained with the RNA-sequencing/TopHat-Fusion software and &#x2018;grep&#x2019; command, PCR amplifications were performed using forward <italic>TBL1XR1</italic> and reverse <italic>HMGA1</italic> primers corresponding to sequences located upstream and downstream of the putative breakpoint, respectively. PCR with the two primer combinations, TBL1XR1-229F1/DB01170-intr2R1 and TBL1XR1-229F1 and HMGA1-324R1, amplified fragments from the cDNA of splenic hemangioma but not from cDNA of the normal spleen. The results strongly suggested the presence of <italic>TBL1XR1-HMGA1</italic> chimeric transcript in splenic hemangioma (<xref rid="f3-ijo-48-03-1242" ref-type="fig">Fig. 3A</xref>). Direct Sanger sequencing of the amplified fragments showed that both were <italic>TBL1XR1-HMGA1</italic> chimeric cDNA fragments with the fusion point identical to that found with TopHat-Fusion and the &#x2018;grep&#x2019; command, i.e., the fusion had occurred between nt 496 of <italic>TBL1XR1</italic> mRNA reference sequence NM_024665.4 and nt 215 of the sequence with accession number DB051170.1 (<xref rid="f3-ijo-48-03-1242" ref-type="fig">Fig. 3B</xref>).</p>
        <p>Genomic PCR with the primer combination TBL1XR1-intron4-F1/DB051170-intr2R1 amplified a fragment from the DNA of the splenic hemangioma. Direct Sanger sequencing showed that it was a genomic hybrid DNA fragment with sequences from the <italic>TBL1XR1</italic> and <italic>HMGA1</italic> genes (<xref rid="f4-ijo-48-03-1242" ref-type="fig">Fig. 4B</xref>). The junction point was identical to the fusion point found with TopHat-Fusion and the &#x2018;grep&#x2019; command and with RT-PCR.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>We describe the first cytogenetic and molecular genetic analysis of a splenic hemangioma. The tumor had an acquired chromosomal translocation, t(3;6)(q26;p21), which resulted in fusion of the <italic>TBL1XR1</italic> (from 3q26) and <italic>HMGA1</italic> (from 6p21) genes. The fact that an acquired genetic aberration was found in the splenic hemangioma cells argues strongly that the disease is neoplastic.</p>
      <p>The protein encoded by the <italic>TBL1XR1</italic> gene has sequence similarity with members of the WD40 repeat-containing protein family (<xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). The WD40 group is a large family of proteins which appear to have a regulatory function (<xref rid="b19-ijo-48-03-1242" ref-type="bibr">19</xref>&#x2013;<xref rid="b21-ijo-48-03-1242" ref-type="bibr">21</xref>). WD40 repeats mediate protein-protein interactions and members of the family are involved in signal transduction, RNA processing, gene regulation, vesicular trafficking, cytoskeletal assembly, and they may also play a role in the control of cytotypic differentiation (<xref rid="b19-ijo-48-03-1242" ref-type="bibr">19</xref>&#x2013;<xref rid="b21-ijo-48-03-1242" ref-type="bibr">21</xref>). TBL1XR1 is a core component of NCoR (nuclear receptor corepressor) and SMRT (silencing mediator of retinoic acid and thyroid hormone receptors) repressor complexes and is essential in targeting SMRT/NCoR corepressor complexes to the promoter of target genes. It is also required for transcriptional activation by nuclear receptors and other regulated transcription factors (<xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). TBL1XR1 is further essential in the activation of Wnt-&#x3B2;-catenin and NF-&#x3BA;B signaling pathways (<xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). <italic>De novo</italic> deletions and recurrent mutations have been identified in the <italic>TBL1XR1</italic> gene and are linked to intellectual disability (<xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). <italic>TBL1XR1</italic> plays an important role in tumorigenesis, invasion, metastasis, and the development of therapy resistance (<xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). <italic>TBL1XR1</italic> is overexpressed in primary lung squamous cell carcinoma, breast cancer, cervical cancer, nasopharyngeal carcinoma, esophageal squamous cell carcinoma, and invasive prostate cancer (reviewed in ref. <xref rid="b18-ijo-48-03-1242" ref-type="bibr">18</xref>). Mutation of <italic>TBL1XR1</italic> was found in primary central nervous system lymphomas (<xref rid="b22-ijo-48-03-1242" ref-type="bibr">22</xref>,<xref rid="b23-ijo-48-03-1242" ref-type="bibr">23</xref>). Deletions of <italic>TBL1XR1</italic> were described in 15% of <italic>ETV6-RUNX1</italic> positive acute lymphoblastic leukemias (<xref rid="b24-ijo-48-03-1242" ref-type="bibr">24</xref>). In frame <italic>TBL1XR1</italic> chimeric transcripts which code for chimeric proteins, were found in different neoplasias. A recurrent <italic>TBL1XR1-TP63</italic> fusion gene was reported in diffuse large B-cell lymphoma, peripheral T-cell lymphoma, and follicular lymphoma which was the result of a chromosomal rearrangement between 3q26 (<italic>TBL1XR1</italic>) and 3q28 (<italic>TP63</italic>) (<xref rid="b25-ijo-48-03-1242" ref-type="bibr">25</xref>,<xref rid="b26-ijo-48-03-1242" ref-type="bibr">26</xref>). In most of the cases, the exons 1&#x2013;7 of <italic>TBL1XR1</italic> were fused in frame to exons 4&#x2013;8 or 4&#x2013;10 of <italic>TP63</italic>. Exon 14 or exon 4 of <italic>TBL1XR1</italic> was involved in the remaining cases (<xref rid="b25-ijo-48-03-1242" ref-type="bibr">25</xref>,<xref rid="b26-ijo-48-03-1242" ref-type="bibr">26</xref>).</p>
      <p><italic>TBL1XR1</italic> is fused to <italic>RARA</italic> in an acute promyelocytic leukemia carrying a variant t(3;17)(q26;q21) translocation (<xref rid="b27-ijo-48-03-1242" ref-type="bibr">27</xref>). The TBL1XR1-RARA fusion protein was predominantly localized in the nucleus, formed homodimers or heterodimers with retinoid X receptor &#x3B1;, and acted as transcriptional activator in the presence of ligand. In the presence of pharmacologic doses of ATRA, TBLR1-RARA protein could be degraded, and its homodimerization was abrogated (<xref rid="b27-ijo-48-03-1242" ref-type="bibr">27</xref>).</p>
      <p>Fusions of <italic>TBL1XR1</italic> resulting in promoter swapping were also found (<xref rid="b28-ijo-48-03-1242" ref-type="bibr">28</xref>,<xref rid="b29-ijo-48-03-1242" ref-type="bibr">29</xref>). In the breast carcinoma MCB7 cell line, the untranslated (5&#x2032;-UTR) exon 1 of <italic>TBL1XR1</italic> is fused with the start codon-bearing exon 2 of <italic>RGS17</italic>, generating a fusion gene that encodes the full-length RGS17 protein under the control of <italic>TBL1XR1</italic> gene promoter (<xref rid="b28-ijo-48-03-1242" ref-type="bibr">28</xref>). The same 5&#x2032;-UTR exon 1 of <italic>TBL1XR1</italic> was also found to be fused with the <italic>PIK3CA</italic> gene in breast cancer and prostate adenocarcinomas. The result was again the expression of <italic>PIK3CA</italic> which came under the control of the <italic>TBL1XR1</italic> promoter (<xref rid="b29-ijo-48-03-1242" ref-type="bibr">29</xref>).</p>
      <p>The <italic>HMGA1</italic> gene encodes a non-histone protein involved in many cellular processes, including regulation of inducible gene transcription, integration of retroviruses into chromosomes, and the metastatic progression of cancer cells (<xref rid="b30-ijo-48-03-1242" ref-type="bibr">30</xref>&#x2013;<xref rid="b32-ijo-48-03-1242" ref-type="bibr">32</xref>). The encoded protein preferentially binds to the minor groove of A+T-rich regions in double-stranded DNA. It has little secondary structure in solution but assumes distinct conformations when bound to substrates such as DNA or other proteins. The encoded protein is frequently acetylated and is found in the nucleus. Six transcript variants were identified encoding two different isoforms (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene/3159">http://www.ncbi.nlm.nih.gov/gene/3159</ext-link>). However, expressed sequence tags (EST) indicate that additional alternative splicing exists with various 5&#x2032;-UTR sequences occurring in different tissues. For example, the EST with accession numbers DB051170 and DB03591 are found in testis, EST BM845429 in lymph node, CN350278 in embryonic stem cells, DC338100 in brain, and DA921912 is found in the small intestine. These splicing variants may be regulated by alternative promoters of <italic>HMGA1</italic> (<xref rid="b17-ijo-48-03-1242" ref-type="bibr">17</xref>).</p>
      <p><italic>HMGA1</italic> is overexpressed in poorly differentiated cancers originating from all three germ layers, suggesting that it plays a fundamental role in tumorigenesis regardless of the cell type from which the tumor begins. High expression of the <italic>HMGA1</italic> gene or high levels of HMGA1 protein were found in cancers of the thyroid, lung, breast, bladder, prostate, colon, pancreas, uterine corpus, uterine cervix, kidney, head and neck, nervous system, stomach, liver, and hematopoietic system. Expression studies reveal that <italic>HMGA1</italic> overexpression correlates with adverse clinical outcomes in cancers (<xref rid="b33-ijo-48-03-1242" ref-type="bibr">33</xref>&#x2013;<xref rid="b35-ijo-48-03-1242" ref-type="bibr">35</xref>).</p>
      <p>The basis for <italic>HMGA1</italic> overexpression is not well understood but it seems that <italic>HMGA1</italic> expression is induced through different pathways. For example, <italic>HMGA1</italic> expression was shown to be induced by cMYC and AP1 transcription factors (<xref rid="b36-ijo-48-03-1242" ref-type="bibr">36</xref>,<xref rid="b37-ijo-48-03-1242" ref-type="bibr">37</xref>). Recent studies suggest that microRNAs regulate <italic>HMGA1</italic> in some types of cancer (<xref rid="b38-ijo-48-03-1242" ref-type="bibr">38</xref>&#x2013;<xref rid="b40-ijo-48-03-1242" ref-type="bibr">40</xref>). Another recent study showed that HMGA1 was an immediate target of the &#x3B2;-catenin/TCF-4 signaling pathway in colon cancer (<xref rid="b41-ijo-48-03-1242" ref-type="bibr">41</xref>).</p>
      <p>Dysregulation of <italic>HMGA1</italic> as a result of specific chromosomal rearrangements involving chromosomal region 6p21.3 has also been identified in a variety of common benign mesenchymal tumors such as lipomas, uterine leiomyomas, endometrial polyps, and pulmonary hamartomas (<xref rid="b42-ijo-48-03-1242" ref-type="bibr">42</xref>&#x2013;<xref rid="b51-ijo-48-03-1242" ref-type="bibr">51</xref>). The breakpoints in most tumors are located 3&#x2032; of <italic>HMGA1</italic>, but 5&#x2032; or intragenic breakpoints have also been reported (<xref rid="b42-ijo-48-03-1242" ref-type="bibr">42</xref>,<xref rid="b43-ijo-48-03-1242" ref-type="bibr">43</xref>,<xref rid="b46-ijo-48-03-1242" ref-type="bibr">46</xref>,<xref rid="b47-ijo-48-03-1242" ref-type="bibr">47</xref>). The findings we present indicate that a similar pathogenetic mechanism may be operative also in splenic hemangioma. Whether any systematic tumorigenic differences exist between this and the other benign neoplasias is a question that can be answered only after many more splenic hemangiomas are genetically analyzed.</p>
      <p>So far, only one <italic>HMGA1</italic>-fusion transcript has been described in the literature: an <italic>HMGA1-LAMA4</italic> found in a pulmonary hamartoma as a result of inv(<xref rid="b6-ijo-48-03-1242" ref-type="bibr">6</xref>)(p21q21) (<xref rid="b46-ijo-48-03-1242" ref-type="bibr">46</xref>). Fusion of <italic>HMGA1</italic> to the intergenic region between <italic>LPP</italic> and <italic>TPRG1</italic> in a lipoma carrying a t(3;6)(q27;p21) has also been reported (<xref rid="b52-ijo-48-03-1242" ref-type="bibr">52</xref>).</p>
      <p>The present t(3;6)(q26;p21) chromosomal rearrangement would have molecular consequences for both <italic>TBL1XR1</italic> and <italic>HMGA1</italic>. The <italic>TBL1XR1</italic> gene would have only a single functional copy of the gene left in the cell, while the other, rearranged allele would produce a putative truncated form of TBL1XR1 protein containing the LiSH and F-box-like domains (NP_078941; LiSH domain: 4&#x2013;32, F-box-like domain: 41&#x2013;86). Thus, the truncated form of TBL1XR1, through the LisH and F-box-like domains, could participate in protein dimerization, affect protein half-life, and could influence specific cellular localizations (<xref rid="b53-ijo-48-03-1242" ref-type="bibr">53</xref>,<xref rid="b54-ijo-48-03-1242" ref-type="bibr">54</xref>).</p>
      <p>With regard to <italic>HMGA1</italic>, the <italic>TBL1XR1-HMGA1</italic> fusion transcript leads untranslated exons of <italic>HMGA1</italic> to be replaced by the first 5 exons of the <italic>TBL1XR1</italic> gene. The result is that the entire coding region of <italic>HMGA1</italic> comes under the control of the <italic>TBL1XR1</italic> promoter leading to dysregulation of <italic>HMGA1</italic>.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This study was supported by grants from the Norwegian Radium Hospital Foundation.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="b1-ijo-48-03-1242">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willcox</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Speer</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Schlinkert</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Sarr</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Hemangioma of the spleen: Presentation, diagnosis, and management</article-title>
          <source>J Gastrointest Surg</source>
          <volume>4</volume>
          <fpage>611</fpage>
          <lpage>613</lpage>
          <year>2000</year>
          <pub-id pub-id-type="doi">10.1016/S1091-255X(00)80110-9</pub-id>
          <pub-id pub-id-type="pmid">11307096</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-ijo-48-03-1242">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husni</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>The clinical course of splenic hemangioma with emphasis on spontaneous rupture</article-title>
          <source>Arch Surg</source>
          <volume>83</volume>
          <fpage>681</fpage>
          <lpage>688</lpage>
          <year>1961</year>
          <pub-id pub-id-type="doi">10.1001/archsurg.1961.01300170037008</pub-id>
          <pub-id pub-id-type="pmid">14450201</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-ijo-48-03-1242">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arber</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Strickler</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Splenic vascular tumors: A histologic, immunophenotypic, and virologic study</article-title>
          <source>Am J Surg Pathol</source>
          <volume>21</volume>
          <fpage>827</fpage>
          <lpage>835</lpage>
          <year>1997</year>
          <pub-id pub-id-type="doi">10.1097/00000478-199707000-00011</pub-id>
          <pub-id pub-id-type="pmid">9236839</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-ijo-48-03-1242">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kutok</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Splenic vascular tumors</article-title>
          <source>Semin Diagn Pathol</source>
          <volume>20</volume>
          <fpage>128</fpage>
          <lpage>139</lpage>
          <year>2003</year>
          <pub-id pub-id-type="doi">10.1016/S0740-2570(03)00011-X</pub-id>
          <pub-id pub-id-type="pmid">12945936</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-ijo-48-03-1242">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbott</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Aguilera</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Gorospe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation</article-title>
          <source>Radiographics</source>
          <volume>24</volume>
          <fpage>1137</fpage>
          <lpage>1163</lpage>
          <year>2004</year>
          <pub-id pub-id-type="doi">10.1148/rg.244045006</pub-id>
          <pub-id pub-id-type="pmid">15256634</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-ijo-48-03-1242">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halgrimson</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Rustad</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Zeligman</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Calcified hemangioma of the spleen</article-title>
          <source>JAMA</source>
          <volume>252</volume>
          <fpage>2959</fpage>
          <lpage>2960</lpage>
          <year>1984</year>
          <pub-id pub-id-type="doi">10.1001/jama.1984.03350210015015</pub-id>
          <pub-id pub-id-type="pmid">6502853</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-ijo-48-03-1242">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McIntosh</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous rupture of a splenic vascular malformation. A report of three cases and review of the literature</article-title>
          <source>J R Coll Surg Edinb</source>
          <volume>32</volume>
          <fpage>346</fpage>
          <lpage>347</lpage>
          <year>1987</year>
          <pub-id pub-id-type="pmid">3329224</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-ijo-48-03-1242">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Ghose</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sawhney</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hemangioma of spleen with spontaneous, extra-peritoneal rupture, with associated splenic tuberculosis - an unusual presentation</article-title>
          <source>Australas Radiol</source>
          <volume>37</volume>
          <fpage>100</fpage>
          <lpage>101</lpage>
          <year>1993</year>
          <pub-id pub-id-type="doi">10.1111/j.1440-1673.1993.tb00025.x</pub-id>
          <pub-id pub-id-type="pmid">8323494</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-ijo-48-03-1242">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pachl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Elmalik</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kamupira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Murthi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Ruptured splenic cavernous hemangioma in a neonate</article-title>
          <source>J Pediatr Surg</source>
          <volume>43</volume>
          <fpage>407</fpage>
          <lpage>409</lpage>
          <year>2008</year>
          <pub-id pub-id-type="doi">10.1016/j.jpedsurg.2007.09.080</pub-id>
          <pub-id pub-id-type="pmid">18280302</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-ijo-48-03-1242">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>D'Alfonso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nallbani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Palermo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Franchi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Patacchiola</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous rupture of splenic hemangioma in puerperium</article-title>
          <source>Clin Exp Obstet Gynecol</source>
          <volume>39</volume>
          <fpage>407</fpage>
          <lpage>408</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">23157060</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-ijo-48-03-1242">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kang</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YY</given-names>
            </name>
          </person-group>
          <article-title>Blunt abdominal injury with rupture of giant hepatic cavernous hemangioma and laceration of the spleen</article-title>
          <source>Hepatobiliary Pancreat Dis Int</source>
          <volume>14</volume>
          <fpage>109</fpage>
          <lpage>110</lpage>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.1016/S1499-3872(14)60310-6</pub-id>
          <pub-id pub-id-type="pmid">25655300</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-ijo-48-03-1242">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoeger</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Helmke</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Chronic consumption coagulopathy due to an occult splenic haemangioma: Kasabach-Merritt syndrome</article-title>
          <source>Eur J Pediatr</source>
          <volume>154</volume>
          <fpage>365</fpage>
          <lpage>368</lpage>
          <year>1995</year>
          <pub-id pub-id-type="doi">10.1007/BF02072104</pub-id>
          <pub-id pub-id-type="pmid">7641767</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-ijo-48-03-1242">
        <label>13</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Schaffer</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Slovak</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <source>ISCN 2009: an International System for Human Cytogenetic Nomenclature</source>
          <publisher-name>Karger</publisher-name>
          <publisher-loc>Basel</publisher-loc>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="b14-ijo-48-03-1242">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pertea</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Trapnell</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kelley</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>
          <source>Genome Biol</source>
          <volume>14</volume>
          <fpage>R36</fpage>
          <year>2013</year>
          <pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id>
          <!--<pub-id pub-id-type="pmcid">4053844</pub-id>-->
          <pub-id pub-id-type="pmid">23618408</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-ijo-48-03-1242">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>TopHat-Fusion: An algorithm for discovery of novel fusion transcripts</article-title>
          <source>Genome Biol</source>
          <volume>12</volume>
          <fpage>R72</fpage>
          <year>2011</year>
          <pub-id pub-id-type="doi">10.1186/gb-2011-12-8-r72</pub-id>
          <!--<pub-id pub-id-type="pmcid">3245612</pub-id>-->
          <pub-id pub-id-type="pmid">21835007</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-ijo-48-03-1242">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panagopoulos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gorunova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bjerkehagen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Heim</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12)</article-title>
          <source>PLoS One</source>
          <volume>10</volume>
          <fpage>e0124288</fpage>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0124288</pub-id>
          <!--<pub-id pub-id-type="pmcid">4397011</pub-id>-->
          <pub-id pub-id-type="pmid">25875009</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-ijo-48-03-1242">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wakamatsu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sekine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsuritani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wakaguri</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes</article-title>
          <source>Genome Res</source>
          <volume>16</volume>
          <fpage>55</fpage>
          <lpage>65</lpage>
          <year>2006</year>
          <pub-id pub-id-type="doi">10.1101/gr.4039406</pub-id>
          <!--<pub-id pub-id-type="pmcid">1356129</pub-id>-->
          <pub-id pub-id-type="pmid">16344560</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-ijo-48-03-1242">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>TBL1XR1 in physiological and pathological states</article-title>
          <source>Am J Clin Exp Urol</source>
          <volume>3</volume>
          <fpage>13</fpage>
          <lpage>23</lpage>
          <year>2015</year>
          <!--<pub-id pub-id-type="pmcid">4446378</pub-id>-->
          <pub-id pub-id-type="pmid">26069883</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-ijo-48-03-1242">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Structure and function of WD40 domain proteins</article-title>
          <source>Protein Cell</source>
          <volume>2</volume>
          <fpage>202</fpage>
          <lpage>214</lpage>
          <year>2011</year>
          <pub-id pub-id-type="doi">10.1007/s13238-011-1018-1</pub-id>
          <pub-id pub-id-type="pmid">21468892</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-ijo-48-03-1242">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>WD-repeat proteins: Structure characteristics, biological function, and their involvement in human diseases</article-title>
          <source>Cell Mol Life Sci</source>
          <volume>58</volume>
          <fpage>2085</fpage>
          <lpage>2097</lpage>
          <year>2001</year>
          <pub-id pub-id-type="doi">10.1007/PL00000838</pub-id>
          <pub-id pub-id-type="pmid">11814058</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-ijo-48-03-1242">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neer</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Nambudripad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>The ancient regulatory-protein family of WD-repeat proteins</article-title>
          <source>Nature</source>
          <volume>371</volume>
          <fpage>297</fpage>
          <lpage>300</lpage>
          <year>1994</year>
          <pub-id pub-id-type="doi">10.1038/371297a0</pub-id>
          <pub-id pub-id-type="pmid">8090199</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-ijo-48-03-1242">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tateishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Niwa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsushita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Arita</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas</article-title>
          <source>Neuropathol Appl Neurobiol</source>
          <month>6</month>
          <day>25</day>
          <year>2015</year>
          <comment>Epub ahead of print</comment>
          <pub-id pub-id-type="doi">10.1111/nan.12259</pub-id>
          <pub-id pub-id-type="pmid">26111727</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-ijo-48-03-1242">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Aguilar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Idbaih</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boisselier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Habbita</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rossetto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laurenge</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jouvet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Polivka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adam</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas</article-title>
          <source>Clin Cancer Res</source>
          <volume>18</volume>
          <fpage>5203</fpage>
          <lpage>5211</lpage>
          <year>2012</year>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-0845</pub-id>
          <pub-id pub-id-type="pmid">22837180</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-ijo-48-03-1242">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Barber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Case</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Konn</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>FM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>47</volume>
          <fpage>1118</fpage>
          <lpage>1125</lpage>
          <year>2008</year>
          <pub-id pub-id-type="doi">10.1002/gcc.20613</pub-id>
          <pub-id pub-id-type="pmid">18767146</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-ijo-48-03-1242">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Mungall</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Ben-Neriah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rogic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morin</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Slack</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Connors</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TBL1XR1/TP63: A novel recurrent gene fusion in B-cell non-Hodgkin lymphoma</article-title>
          <source>Blood</source>
          <volume>119</volume>
          <fpage>4949</fpage>
          <lpage>4952</lpage>
          <year>2012</year>
          <pub-id pub-id-type="doi">10.1182/blood-2012-02-414441</pub-id>
          <!--<pub-id pub-id-type="pmcid">3367896</pub-id>-->
          <pub-id pub-id-type="pmid">22496164</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-ijo-48-03-1242">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vasmatzis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Knudson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ketterling</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Braggio</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Viswanatha</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Kip</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Ozsan</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas</article-title>
          <source>Blood</source>
          <volume>120</volume>
          <fpage>2280</fpage>
          <lpage>2289</lpage>
          <year>2012</year>
          <pub-id pub-id-type="doi">10.1182/blood-2012-03-419937</pub-id>
          <pub-id pub-id-type="pmid">22855598</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-ijo-48-03-1242">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ru</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TBLR1 fuses to retinoid acid receptor &#x3B1; in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia</article-title>
          <source>Blood</source>
          <volume>124</volume>
          <fpage>936</fpage>
          <lpage>945</lpage>
          <year>2014</year>
          <pub-id pub-id-type="doi">10.1182/blood-2013-10-528596</pub-id>
          <pub-id pub-id-type="pmid">24782508</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-ijo-48-03-1242">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hahn</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bera</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Gehlhaus</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kirsch</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Pastan</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>101</volume>
          <fpage>13257</fpage>
          <lpage>13261</lpage>
          <year>2004</year>
          <pub-id pub-id-type="doi">10.1073/pnas.0405490101</pub-id>
          <!--<pub-id pub-id-type="pmcid">516526</pub-id>-->
          <pub-id pub-id-type="pmid">15326299</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-ijo-48-03-1242">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stransky</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cerami</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schalm</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lengauer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The landscape of kinase fusions in cancer</article-title>
          <source>Nat Commun</source>
          <volume>5</volume>
          <fpage>4846</fpage>
          <year>2014</year>
          <pub-id pub-id-type="doi">10.1038/ncomms5846</pub-id>
          <!--<pub-id pub-id-type="pmcid">4175590</pub-id>-->
          <pub-id pub-id-type="pmid">25204415</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-ijo-48-03-1242">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benecke</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Eilebrecht</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Benecke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eilebrecht</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>RNA-mediated regulation of HMGA1 function</article-title>
          <source>Biomolecules</source>
          <volume>5</volume>
          <fpage>943</fpage>
          <lpage>957</lpage>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.3390/biom5020943</pub-id>
          <!--<pub-id pub-id-type="pmcid">4496703</pub-id>-->
          <pub-id pub-id-type="pmid">26117853</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-ijo-48-03-1242">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beckerbauer</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>HMGI/Y proteins: Flexible regulators of transcription and chromatin structure</article-title>
          <source>Biochim Biophys Acta</source>
          <volume>1519</volume>
          <fpage>13</fpage>
          <lpage>29</lpage>
          <year>2001</year>
          <pub-id pub-id-type="doi">10.1016/S0167-4781(01)00215-9</pub-id>
          <pub-id pub-id-type="pmid">11406267</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-ijo-48-03-1242">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Resar</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>The high mobility group A1 gene: Transforming inflammatory signals into cancer?</article-title>
          <source>Cancer Res</source>
          <volume>70</volume>
          <fpage>436</fpage>
          <lpage>439</lpage>
          <year>2010</year>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-1212</pub-id>
          <!--<pub-id pub-id-type="pmcid">2807996</pub-id>-->
          <pub-id pub-id-type="pmid">20068164</pub-id>
        </element-citation>
      </ref>
      <ref id="b33-ijo-48-03-1242">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer</article-title>
          <source>Tumour Biol</source>
          <volume>36</volume>
          <fpage>1213</fpage>
          <lpage>1219</lpage>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.1007/s13277-014-2749-4</pub-id>
          <pub-id pub-id-type="pmid">25344216</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-ijo-48-03-1242">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer</article-title>
          <source>Mol Cell Biochem</source>
          <volume>404</volume>
          <fpage>251</fpage>
          <lpage>257</lpage>
          <year>2015</year>
          <pub-id pub-id-type="doi">10.1007/s11010-015-2384-4</pub-id>
          <pub-id pub-id-type="pmid">25772486</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-ijo-48-03-1242">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liau</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Matros</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Redston</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Whang</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma</article-title>
          <source>Cancer</source>
          <volume>113</volume>
          <fpage>302</fpage>
          <lpage>314</lpage>
          <year>2008</year>
          <pub-id pub-id-type="doi">10.1002/cncr.23560</pub-id>
          <!--<pub-id pub-id-type="pmcid">2997611</pub-id>-->
          <pub-id pub-id-type="pmid">18473350</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-ijo-48-03-1242">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dolde</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Maher</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Bunton</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Resar</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>HMG-I/Y, a new c-Myc target gene and potential oncogene</article-title>
          <source>Mol Cell Biol</source>
          <volume>20</volume>
          <fpage>5490</fpage>
          <lpage>5502</lpage>
          <year>2000</year>
          <pub-id pub-id-type="doi">10.1128/MCB.20.15.5490-5502.2000</pub-id>
          <!--<pub-id pub-id-type="pmcid">86000</pub-id>-->
          <pub-id pub-id-type="pmid">10891489</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-ijo-48-03-1242">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dhar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reeves</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Resar</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Colburn</surname>
              <given-names>NH</given-names>
            </name>
          </person-group>
          <article-title>Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation</article-title>
          <source>Oncogene</source>
          <volume>23</volume>
          <fpage>4466</fpage>
          <lpage>4476</lpage>
          <year>2004</year>
          <pub-id pub-id-type="doi">10.1038/sj.onc.1207581</pub-id>
          <pub-id pub-id-type="pmid">15064752</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-ijo-48-03-1242">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>XX</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>QZ</given-names>
            </name>
            <name>
              <surname>Mu</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Bo</surname>
              <given-names>QA</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>GZ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>GQ</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>FP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer</article-title>
          <source>Int J Clin Exp Pathol</source>
          <volume>8</volume>
          <fpage>368</fpage>
          <lpage>373</lpage>
          <year>2015</year>
          <!--<pub-id pub-id-type="pmcid">4348937</pub-id>-->
          <pub-id pub-id-type="pmid">25755724</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-ijo-48-03-1242">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1</article-title>
          <source>Int J Oncol</source>
          <volume>46</volume>
          <fpage>2526</fpage>
          <lpage>2534</lpage>
          <year>2015</year>
          <pub-id pub-id-type="pmid">25846193</pub-id>
        </element-citation>
      </ref>
      <ref id="b40-ijo-48-03-1242">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1</article-title>
          <source>Cell Physiol Biochem</source>
          <volume>33</volume>
          <fpage>1329</fpage>
          <lpage>1339</lpage>
          <year>2014</year>
          <pub-id pub-id-type="doi">10.1159/000358700</pub-id>
          <pub-id pub-id-type="pmid">24803022</pub-id>
        </element-citation>
      </ref>
      <ref id="b41-ijo-48-03-1242">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bush</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Brock</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>RA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Sumter</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>The Wnt/&#x3B2;-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer</article-title>
          <source>Cell Biochem Funct</source>
          <volume>31</volume>
          <fpage>228</fpage>
          <lpage>236</lpage>
          <year>2013</year>
          <pub-id pub-id-type="doi">10.1002/cbf.2876</pub-id>
          <!--<pub-id pub-id-type="pmcid">3616152</pub-id>-->
          <pub-id pub-id-type="pmid">22961697</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-ijo-48-03-1242">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bol</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wanschura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bartnitzke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>17</volume>
          <fpage>191</fpage>
          <lpage>193</lpage>
          <year>1996</year>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199611)17:3&lt;191::AID-GCC8&gt;3.0.CO;2-#</pub-id>
          <pub-id pub-id-type="pmid">8946199</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-ijo-48-03-1242">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wanschura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rommel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bartnitzke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings</article-title>
          <source>J Natl Cancer Inst</source>
          <volume>88</volume>
          <fpage>1234</fpage>
          <lpage>1236</lpage>
          <year>1996</year>
          <pub-id pub-id-type="doi">10.1093/jnci/88.17.1234</pub-id>
          <pub-id pub-id-type="pmid">8780634</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-ijo-48-03-1242">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wanschura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Christiaens</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Van den Berghe</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Moerman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Polito</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Van den Berghe</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>20</volume>
          <fpage>90</fpage>
          <lpage>92</lpage>
          <year>1997</year>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199709)20:1&lt;90::AID-GCC13&gt;3.0.CO;2-J</pub-id>
          <pub-id pub-id-type="pmid">9290959</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-ijo-48-03-1242">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm</article-title>
          <source>Am J Pathol</source>
          <volume>150</volume>
          <fpage>911</fpage>
          <lpage>918</lpage>
          <year>1997</year>
          <!--<pub-id pub-id-type="pmcid">1857869</pub-id>-->
          <pub-id pub-id-type="pmid">9060829</pub-id>
        </element-citation>
      </ref>
      <ref id="b46-ijo-48-03-1242">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lux</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Reeves</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma</article-title>
          <source>Am J Pathol</source>
          <volume>150</volume>
          <fpage>901</fpage>
          <lpage>910</lpage>
          <year>1997</year>
          <!--<pub-id pub-id-type="pmcid">1857887</pub-id>-->
          <pub-id pub-id-type="pmid">9060828</pub-id>
        </element-citation>
      </ref>
      <ref id="b47-ijo-48-03-1242">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wanschura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borrmann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fusco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Van den Berghe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>23</volume>
          <fpage>279</fpage>
          <lpage>285</lpage>
          <year>1998</year>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199812)23:4&lt;279::AID-GCC1&gt;3.0.CO;2-1</pub-id>
          <pub-id pub-id-type="pmid">9824199</pub-id>
        </element-citation>
      </ref>
      <ref id="b48-ijo-48-03-1242">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Meyer-Bolte</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>W&#xF6;ckel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Breightman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rosigkeit</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartnitzke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>26</volume>
          <fpage>125</fpage>
          <lpage>133</lpage>
          <year>1999</year>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199910)26:2&lt;125::AID-GCC4&gt;3.0.CO;2-A</pub-id>
          <pub-id pub-id-type="pmid">10469450</pub-id>
        </element-citation>
      </ref>
      <ref id="b49-ijo-48-03-1242">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tallini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vanni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Manfioletti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kazmierczak</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Faa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pauwels</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bullerdiek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giancotti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Van Den Berghe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes</article-title>
          <source>Lab Invest</source>
          <volume>80</volume>
          <fpage>359</fpage>
          <lpage>369</lpage>
          <year>2000</year>
          <pub-id pub-id-type="doi">10.1038/labinvest.3780040</pub-id>
          <pub-id pub-id-type="pmid">10744071</pub-id>
        </element-citation>
      </ref>
      <ref id="b50-ijo-48-03-1242">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medeiros</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Araujo</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Erickson-Johnson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kashyap</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nucci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>HMGA1 and HMGA2 rearrangements in mass-forming endometriosis</article-title>
          <source>Genes Chromosomes Cancer</source>
          <volume>49</volume>
          <fpage>630</fpage>
          <lpage>634</lpage>
          <year>2010</year>
          <pub-id pub-id-type="pmid">20461755</pub-id>
        </element-citation>
      </ref>
      <ref id="b51-ijo-48-03-1242">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nezhad</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Drieschner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Helms</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tadayyon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klemke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Belge</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bartnitzke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burchardt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Frantzen</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>6p21 rearrangements in uterine leiomyomas targeting HMGA1</article-title>
          <source>Cancer Genet Cytogenet</source>
          <volume>203</volume>
          <fpage>247</fpage>
          <lpage>252</lpage>
          <year>2010</year>
          <pub-id pub-id-type="doi">10.1016/j.cancergencyto.2010.08.005</pub-id>
          <pub-id pub-id-type="pmid">21156240</pub-id>
        </element-citation>
      </ref>
      <ref id="b52-ijo-48-03-1242">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zamolyi</surname>
              <given-names>RQ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pannain</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Erickson-Johnson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Fusion of HMGA1 to the LPP/TPRG1 intergenic region in a lipoma identified by mapping paraffin-embedded tissues</article-title>
          <source>Cancer Genet Cytogenet</source>
          <volume>196</volume>
          <fpage>64</fpage>
          <lpage>67</lpage>
          <year>2010</year>
          <pub-id pub-id-type="doi">10.1016/j.cancergencyto.2009.09.003</pub-id>
          <pub-id pub-id-type="pmid">19963137</pub-id>
        </element-citation>
      </ref>
      <ref id="b53-ijo-48-03-1242">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerlitz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Darhin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Giorgio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Reiner</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Novel functional features of the Lis-H domain: Role in protein dimerization, half-life and cellular localization</article-title>
          <source>Cell Cycle</source>
          <volume>4</volume>
          <fpage>1632</fpage>
          <lpage>1640</lpage>
          <year>2005</year>
          <pub-id pub-id-type="doi">10.4161/cc.4.11.2151</pub-id>
          <pub-id pub-id-type="pmid">16258276</pub-id>
        </element-citation>
      </ref>
      <ref id="b54-ijo-48-03-1242">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mateja</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cierpicki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Paduch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Derewenda</surname>
              <given-names>ZS</given-names>
            </name>
            <name>
              <surname>Otlewski</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The dimerization mechanism of LIS1 and its implication for proteins containing the LisH motif</article-title>
          <source>J Mol Biol</source>
          <volume>357</volume>
          <fpage>621</fpage>
          <lpage>631</lpage>
          <year>2006</year>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2006.01.002</pub-id>
          <pub-id pub-id-type="pmid">16445939</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Pathologic examination of the splenic hemangioma. (A) Resected spleen with a well circumscribed hemangioma. (B and C) Microscopic image of splenic hemangioma with blood filled caverns with endothelial cell lining (H&amp;E staining). (D) The vessels are highlighted with CD31 staining. (E) The endothelial cell nuclei are highlighted with ERG staining.</p>
      </caption>
      <graphic xlink:href="IJO-48-03-1242-g00"/>
    </fig>
    <fig id="f2-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Partial karyotype showing the der(3)t(3;6)(q26;p21) and der(6)t(3;6) (q26;p21) together with the corresponding normal chromosome homologs; breakpoint positions are indicated by arrows.</p>
      </caption>
      <graphic xlink:href="IJO-48-03-1242-g01"/>
    </fig>
    <fig id="f3-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>RT-PCR analyses of splenic hemangioma (H) together with normal spleen (S). (A) Amplification of an <italic>ABL1</italic> cDNA fragment using the primers ABL1-91F1 and ABL1-404R1. (B) Amplification of a cDNA fragment using the primers TBL1XR1-229F1 and DB051170-Intr2R1. (C) Amplification of a cDNA fragment using the primers TBL1XR1-229F1 and HMGA1-324R1. M, 1 kb DNA ladder (GeneRuler, Fermentas); Bl, blank, water in cDNA synthesis. (D) Partial sequence chromatogram of the cDNA fragment showing the fusion (arrow) of <italic>TBL1XR1</italic> with <italic>HMGA1</italic> (sequence with accession number DB051170).</p>
      </caption>
      <graphic xlink:href="IJO-48-03-1242-g02"/>
    </fig>
    <fig id="f4-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Genomic PCR analysis of splenic hemangioma (H). (A) Amplification of genomic DNA fragment using the primers TBL1XR1-intron4-F1 and DB051170-intr2R1. (B) Direct Sanger sequencing showed that the amplicon is a genomic hybrid DNA fragment with sequences from <italic>TBL1XR1</italic> and <italic>HMGA1</italic>. The primers are shown in boxes. Arrow indicates the genomic breakpoint. Capital letters show part of exon 5 of <italic>TBL1XR1</italic>. (C) The <italic>TBL1XR1</italic> gene. The location of <italic>TBL1XR1</italic> on chromosome 3 (vertical line) and the reference sequence NM_024665 are shown. (D) The <italic>HMGA1</italic> gene. The location of <italic>HMGA1</italic> on chromosome 6 (vertical line), the 6 reference sequences, and the sequence with the accession number DB051170 are shown.</p>
      </caption>
      <graphic xlink:href="IJO-48-03-1242-g03"/>
    </fig>
    <table-wrap id="tI-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Table I</label>
      <caption>
        <p>Primers used for PCR amplification and Sanger sequencing analyses.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top" align="left" rowspan="1" colspan="1">Name</th>
            <th valign="top" align="center" rowspan="1" colspan="1">Sequence (5&#x2032;&#x2192;3&#x2032;)</th>
            <th valign="top" align="center" rowspan="1" colspan="1">Direction in PCR</th>
            <th valign="top" align="center" rowspan="1" colspan="1">Position on Human Feb. 2009 (GRCh37/hg19) Assembly</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">TBL1XR1-229F1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TGTTGTGACCTCATGGTTTAAGTGG</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Forward</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr3:176,782,774-176,782,798</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">TBL1XR1-intron4-F1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">AAGCAGTCATTTCCAGTTGCTGC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Forward</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr3:176,769,680-176,769,702</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">HMGA1-324R1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">GGACTTCGAGCTCGACTCACTCA</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Reverse</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr6:34,208,559-34,208,581</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">DB051170-Intr2R1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">GTACACCCAAGGGAGGCTTCATAC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Reverse</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr6:34,203,951-34,203,974</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">DB051170-Intr2R2</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TGATCAAGGTGGAGCCTTCCAGC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Reverse</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr6:34,204,001-34,204,023</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ABL1-91F1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">CAGCGGCCAGTAGCATCTGACTTTG</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Forward</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr9:133,729,459-133,729,483</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ABL1-404R1</td>
            <td valign="top" align="left" rowspan="1" colspan="1">CTCAGCAGATACTCAGCGGCATTGC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Reverse</td>
            <td valign="top" align="left" rowspan="1" colspan="1">chr9:133,730,335-133,730,359</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tII-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Table II</label>
      <caption>
        <p>Fusions between chromosome bands 3q26 and 6p21 which were found with the TopHat-Fusion program.<xref rid="tfn1-ijo-48-03-1242" ref-type="table-fn">a</xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top" align="left" rowspan="1" colspan="1">3q26-fusion point</th>
            <th valign="top" align="center" rowspan="1" colspan="1">6p21-fusion point</th>
            <th valign="top" align="center" rowspan="1" colspan="1">Fifty bases on the left side of the fusion (3p21)</th>
            <th valign="top" align="center" rowspan="1" colspan="1">Fifty bases on the right side of the fusion (6p21)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">166506603</td>
            <td valign="top" align="center" rowspan="1" colspan="1">30593594</td>
            <td valign="top" align="left" rowspan="1" colspan="1">GGGATTACAACTCCTCCTGGCATTA<break/>CAGGAGTGAGCCACCATGCCTGGCC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TCTCTTCCCAGTCTACAGCTCCTACAGAGCACTCTGAGGGCCTGTCTGCC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">
              <bold>176769483</bold>
            </td>
            <td valign="top" align="center" rowspan="1" colspan="1">
              <bold>34203899</bold>
            </td>
            <td valign="top" align="left" rowspan="1" colspan="1">
              <bold>CACAATTTTCCAAATCCAGGATGG</bold>
              <break/>
              <bold>TACCTTGTTTGATGGTCGACCAATAG</bold>
            </td>
            <td valign="top" align="left" rowspan="1" colspan="1">
              <bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAA</bold>
            </td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">176799652</td>
            <td valign="top" align="center" rowspan="1" colspan="1">35441544</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TCTTTAGTCAGTATAATTACAGT<break/>ATTGTATATATAATATACAATATAAAA</td>
            <td valign="top" align="left" rowspan="1" colspan="1">CCTAGGTGGGGTTTGGAGGTGGCCTGAGCGATATGCAAACAGTGAGGACC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">161838267</td>
            <td valign="top" align="center" rowspan="1" colspan="1">39157355</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TTGGGTTTGAGACTATAGCTAAA<break/>ATATAATAAAACAAAAAATAACAAATA</td>
            <td valign="top" align="left" rowspan="1" colspan="1">CATTCAGGACACAGTGGGCCAGCCCCAGGGTGAACATCATGGAGAACCCA</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-ijo-48-03-1242">
          <label>a</label>
          <p>The sequences corresponding to <italic>TBL1XR1-HMGA1</italic> fusion are in bold.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tIII-ijo-48-03-1242" orientation="portrait" position="float">
      <label>Table III</label>
      <caption>
        <p>Sequences retrieved with the &#x2018;grep&#x2019; command using the expression &#x2018;CGACCAATAGGTCCCCAAGT&#x2019;.<xref rid="tfn2-ijo-48-03-1242" ref-type="table-fn">a</xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">1</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTATGAAGCCTCCCTTGGGTGTACCTG</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">2</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>ATTTTCCAAATCCAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTAT</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">3</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTATGAAGCCTCCCTTGGGTGTACCTG</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">4</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>GGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTATGAAGCCTCCCTTGGGTGT</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">5</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>AGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCAC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">6</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>ATTTTCCAAATCCAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTAT</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">7</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>GTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTA</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">8</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">9</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CTATCATCCAGAAAGGTCTACAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTG</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">10</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CTATCATCCAGAAAGGTCTACAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTG</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">11</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>CTATCATCCAGAAAGGTCTACAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTG</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">12</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>TTCTATCATCCAGAAAGGTCTACAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">13</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>TTTATTTCTATCATCCAGAAAGGTCTACAGTATGTAGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGT</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">14</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>AGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCAC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">15</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>AGAAGCAGAAGTTAGTATTAATGAGGATGGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCAC</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">16</td>
            <td valign="top" align="left" rowspan="1" colspan="1"><bold>GGTACCTTGTTTGATGGTCGACCAATAG</bold>GTCCCCAAGTGGGCCTGCGTATCTCCAGAACACCATCTAAGTCACCTCAAGGTATGAAGCCTCCCTTGGGTGT</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn2-ijo-48-03-1242">
          <label>a</label>
          <p>The sequences of <italic>TBL1XR1</italic> are in bold.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
